| 1. |
- Holgersson, Jan, et al.
(författare)
-
Characteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection therapies
- 2005
-
Ingår i: Immunology and cell biology. - : Wiley. - 0818-9641 .- 1440-1711. ; 83:6, s. 694-708
-
Tidskriftsartikel (refereegranskat)abstract
- The relative shortage of human organs for transplantation is today the major barrier to a broader use of transplantation as a means of treating patients with end-stage organ failure. This barrier could be partly overcome by an increased use of blood group ABO-incompatible live donors, and such trials are currently underway at several transplant centres. If xenotransplantation can be used clinically in the future, the human organ shortage will, in principle, be eradicated. In both these cases, carbohydrate antigens and the corresponding anti-carbohydrate antibodies are the major primary immunological barriers to overcome. Refined carbohydrate-based therapeutics may permit an increased number of ABO-incompatible transplantations to be carried out, and may remove the initial barriers to clinical xenotransplantation. Here, we will discuss the chemical characteristics of protein-carbohydrate interactions and outline carbohydrate-based antirejection therapies as used today in experimental as well as in clinical settings. Novel mucin-based adsorbers of natural anti-carbohydrate antibodies will also be described.
|
|
| 2. |
- Jansson, Andreas, et al.
(författare)
-
In silico simulations suggest that Th-cell development is regulated by both selective and instructive mechanisms
- 2006
-
Ingår i: Immunology and Cell Biology. - : Nature Publishing Group. - 0818-9641 .- 1440-1711. ; 84:2, s. 218-226
-
Tidskriftsartikel (refereegranskat)abstract
- Th-cell differentiation is highly influenced by the local cytokine environment. Although cytokines such as IL-12 and IL-4 are known to polarize the Th-cell response towards Th1 or Th2, respectively, it is not known whether these cytokines instruct the developmental fate of uncommitted Th cells or select cells that have already been committed through a stochastic process. We present an individual based model that accommodates both stochastic and deterministic processes to simulate the dynamic behaviour of selective versus instructive Th-cell development. The predictions made by each model show distinct behaviours, which are compared with experimental observations. The simulations show that the instructive model generates an exclusive Th1 or Th2 response in the absence of an external cytokine source, whereas the selective model favours coexistence of the phenotypes. A hybrid model, including both instructive and selective development, shows behaviour similar to either the selective or the instructive model dependent on the strength of activation. The hybrid model shows the closest qualitative agreement with a number of well-established experimental observations. The predictions by each model suggest that neither pure selective nor instructive Th development is likely to be functional as exclusive mechanisms in Th1/Th2 development.
|
|
| 3. |
- Jonsdottir, I.H.
(författare)
-
Neuropeptides and their interaction with exercise and immune function
- 2000
-
Ingår i: Immunology and Cell Biology. - Oxford : Blackwell Publishing. - 0818-9641 .- 1440-1711. ; 78:5, s. 562-570
-
Forskningsöversikt (refereegranskat)abstract
- It is known today that the immune system is influenced by various types of psychological and physiological stressors, including physical activity. It is well known that physical activity can influence neuropeptide levels both in the central nervous system as well as in peripheral blood. The reported changes of immune function in response to exercise have been suggested to be partly regulated by the activation of different neuropeptides and the identification of receptors for neuropeptides and steroid hormones on cells of the immune system has created a new dimension in this endocrine-immune interaction. It has also been shown that immune cells are capable of producing neuropeptides, creating a bidirectional link between the nervous and immune systems. The most common neuropeptides mentioned in this context are the endogenous opioids. The activation of endogenous opioid peptides in response to physical exercise is well known in the literature, as well as the immunomodulation mediated by opioid peptides. The role of endogenous opioids in the exercise-induced modulation of immune function is less clear. The present paper will also discuss the role of other neuroendocrine factors, such as substance P, neuropeptide Y and vasoactive intestinal peptide, and pituitary hormones, including growth hormone, prolactin and adrenocorticotrophin, in exercise and their possible effects on immune function.
|
|
| 4. |
|
|
| 5. |
- Barrett, Aidan, et al.
(författare)
-
Role of estrogen signaling in fibroblastic reticular cells for innate and adaptive immune responses in antigen-induced arthritis
- 2024
-
Ingår i: IMMUNOLOGY AND CELL BIOLOGY. - 0818-9641 .- 1440-1711.
-
Tidskriftsartikel (refereegranskat)abstract
- Women are more prone to develop rheumatoid arthritis, with peak incidence occurring around menopause. Estrogen has major effects on the immune system and is protective against arthritis. We have previously shown that treatment with estrogen inhibits inflammation and joint destruction in murine models of arthritis, although the mechanisms involved remain unclear. Fibroblastic reticular cells (FRCs) are specialized stromal cells that generate the three-dimensional structure of lymph nodes (LNs). FRCs are vital for coordinating immune responses from within LNs and are characterized by the expression of the chemokine CCL19, which attracts immune cells. The aim of this study was to determine whether the influence of estrogen on innate and adaptive immune cells in arthritis is mediated by estrogen signaling in FRCs. Conditional knockout mice lacking estrogen receptor alpha (ER alpha) in CCL19-expressing cells (Ccl19-CreER alpha fl/fl) were generated and tested. Ccl19-CreER alpha fl/fl mice and littermate controls were ovariectomized, treated with vehicle or estradiol and subjected to the 28-day-long antigen-induced arthritis model to enable analyses of differentiated T- and B-cell populations and innate cells in LNs by flow cytometry. The results reveal that while the response to estradiol treatment in numbers of FRCs per LN is significantly reduced in mice lacking ER alpha in FRCs, estrogen does not inhibit joint inflammation or markedly affect immune responses in this arthritis model. Thus, this study validates the Ccl19-CreER alpha fl/fl strain for studying estrogen signaling in FRCs within inflammatory diseases, although the chosen arthritis model is deemed unsuitable for addressing this question. This study investigated the influence of signaling through estrogen receptor alpha (ER alpha) in fibroblastic reticular cells (FRCs) on innate and adaptive immune responses using a mouse model where ER alpha was conditionally deleted in CCL19-expressing cells. The results reveal that the deletion of ER alpha in FRCs does not affect the FRC phenotype or LN architecture at steady state while the response of FRCs to estrogen treatment during experimental arthritis is significantly reduced in the conditional knock-out mice. However, ER alpha signaling via FRCs does not inhibit joint inflammation or markedly affect immune responses in the antigen-induced arthritis model. image
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
- Chenoweth, Alicia M., et al.
(författare)
-
Harnessing the immune system via Fc gamma R function in immune therapy : a pathway to next-gen mAbs
- 2020
-
Ingår i: Immunology and Cell Biology. - : WILEY. - 0818-9641 .- 1440-1711. ; 98:4, s. 287-304
-
Forskningsöversikt (refereegranskat)abstract
- The human fragment crystallizable (Fc)gamma receptor (R) interacts with antigen-complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host-protective effector functions that are key to the normal physiology of immune resistance to pathogens. More than 100 therapeutic monoclonal antibodies (mAbs) are approved or in late stage clinical trials, many of which harness the potent Fc gamma R-mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody-dependent killing or phagocytosis but is also true to some degree for the mAbs that neutralize or remove small macromolecules such as cytokines or other Igs. The use of mAb therapeutics has also revealed a "scaffolding" role for Fc gamma R which, in different contexts, may either underpin the therapeutic mAb action such as immune agonism or trigger catastrophic adverse effects. The still unmet therapeutic need in many cancers, inflammatory diseases or emerging infections such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires increased effort on the development of improved and novel mAbs. A more mature appreciation of the immunobiology of individual Fc gamma R function and the complexity of the relationships between Fc gamma Rs and antibodies is fueling efforts to develop more potent "next-gen" therapeutic antibodies. Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor specificity for selective engagement of individual activating Fc gamma Rs or the inhibitory Fc gamma RIIb or alternatively, for the ablation of Fc gamma R interaction altogether. This review touches on recent aspects of Fc gamma R and IgG immunobiology and its relationship with the present and future actions of therapeutic mAbs.
|
|
